MIB is supported by a Scientific Advisory Board of Excellence
The Marseille Immunology Biocluster (MIB) is now guided by an International Scientific Advisory Board (SAB), composed of globally recognized scientists known for their expertise and integrity.
A shared expertise guiding innovation
As an independent body, the SAB ensures the scientific rigor, innovation, and high standards at the core of MIB’s research projects. Chaired by Professor Pedro Romero, a world-renowned immunologist, the board evaluates the scientific quality of the programs developed by the Biocluster.
A true strategic pillar, the SAB plays a key role in supporting MIB’s mission: turning fundamental research into tangible, long-lasting therapeutic advances. Through its critical, independent, and multidisciplinary perspective, the SAB fosters the emergence of a new generation of antibody-based therapies.
Over the next ten years, MIB aims to develop innovative therapies, including a flagship “blockbuster” drug. The SAB plays a central role in this ambition by ensuring the scientific consistency and excellence of MIB’s research directions.
« Scientific excellence is built through dialogue, rigor, and the confrontation of ideas. The SAB supports MIB with this ambition. »
Pedro Romero
President of the Scientific Advisory Boar
Members of the Scientific Advisory Board
The SAB brings together 14 international experts with complementary backgrounds — in immunology, cancer, infectious, autoimmune and inflammatory diseases, and biotechnology — offering a cross-cutting and forward-looking vision to MIB’s strategy.
Chaired by Professor Pedro Romero (Switzerland), the board includes:
Dr. Francesca Barone – United States
Dr. Marie-Caroline Dieu -Nosjean – France
Dr. Raphael Gottardo – Switzerland
Prof. Olivier Lambotte – France
Prof. Jean-Daniel Lelièvre – France
Prof. Sophie Lucas – Belgium
Prof. Alberto Mantovani – Italy
Prof. Xavier Mariette – France
Prof. Miriam Merad – United States
Prof. Lisa F.P. Ng – Singapore
Prof. Erika L. Pearce – United States
Dr. Ulrich Specks – United States
Dr. Nicolai Wagtmann – Denmark
With the support of this international Scientific Advisory Board, MIB reaffirms its commitment to sustainable innovation in the service of patients and to advancing the therapies of tomorrow.
Actualités
